FOXC2 and breast carcinoma: Excess expression of Twist, Snail, TGFβ, or FOXC2 in breast cancer results in cells that are more mesenchymal and are characterized by cancer stem cell (CSC) markers, i.e., CD44+ and CD24-low [73].